Recurrent Non-small Cell Lung Cancer Recruiting Phase 2 Trials for Mitometh (DB12117)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02262325Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for SurgeryTreatment